It has not been approved for weight loss or any other indication by the FDA
Backed by Growing Clinical Literature : Evaluated in phase 2 trials for its effects on body weight, energy intake, and metabolic markers in individuals with overweight or obesity, providing a basis for further translational and mechanistic research
It primes melanogenesis, enhances epidermal antioxidant capacity, and prepares the skin to tolerate UV exposure with greater efficiency and uniformity
Phan, M
Shared Contraindications (CI) / Precautions: People with a personal or family history of medullary thyroid cancer (MTC) or MEN2, or those with a serious allergy to the specific medication
Artzi Z, Kozlovsky A, Nemcovsky CE, Moses O, Tal H, Rohrer MD, et al